Raleigh Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-107
| Closed | -$7.66K | – | 1201 |
|
|
2023
Q4 | $7.66K | Buy |
107
+4
| +4% | +$286 | ﹤0.01% | 655 |
|
|
2023
Q3 | $5.37K | Buy |
103
+42
| +69% | +$2.19K | ﹤0.01% | 679 |
|
|
2023
Q2 | $3.87K | Buy |
61
+20
| +49% | +$1.27K | ﹤0.01% | 687 |
|
|
2023
Q1 | $2.22K | Buy |
41
+9
| +28% | +$487 | ﹤0.01% | 763 |
|
|
2022
Q4 | $1.69K | Buy |
32
+16
| +100% | +$847 | ﹤0.01% | 698 |
|
|
2022
Q3 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 791 |
|